| Literature DB >> 35464592 |
Kadir Karkin1, Ergün Alma1, Ediz Vuruşkan1, Güçlü Gürlen1, Umut Ünal1, Hakan Erçil1, Zafer Gökhan Gürbüz1.
Abstract
INTRODUCTION: The aim of our study is to evaluate the success rates of our retrograde intrarenal surgery operations and the complications we encountered and to determine in which kidney segment the operations were more successful with flexible ureterorenoscopy.Entities:
Keywords: flexible ureteroscopy; kidney; kidney stone; pelvis stone; retrograde intrarenal surgery
Year: 2022 PMID: 35464592 PMCID: PMC9015064 DOI: 10.7759/cureus.23307
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Preoperative demographic data
M: male; F: female; Hct: hematocrit
| Stone Localization | ||||||||
| Lower | Multiple | Middle | Pelvis | Upper | P-value | |||
| Number | 186 | 42 | 204 | 612 | 84 | |||
| Gender | M | n(%) | 78(41.9) | 12(28.6) | 96(47.1) | 378(61.8) | 54(64.3) | 0.119 |
| F | n(%) | 108(58.1) | 30(71.4) | 108(52.9) | 234(38.2) | 30(35.7) | ||
| Side | Left | n(%) | 66(35.5) | 24(57.1) | 90(44.1) | 312(51.0) | 60(71.4) | 0.218 |
| Right | n(%) | 120(64.5) | 18(42.9) | 114(55.9) | 300(49.0) | 24(28.6) | ||
| Radiopacity | Yes | n(%) | 168(90.3) | 42(100) | 198(97.1) | 564(87.3) | 72(85.7) | 0.439 |
| No | n(%) | 18(9.7) | 0(0.0) | 6(2.9) | 48(12.7) | 12(14.3) | ||
| Preoperative Stent | Yes | n(%) | 84(45.2) | 12(28.6) | 36(17.6) | 132(21.6) | 18(21.4) | 0.075 |
| No | n(%) | 102(54.8) | 30(71.4) | 168(82.4) | 480(78.4) | 66(78.6) | ||
| Age | 42.3+14.4 | 43.7+10.8 | 41.9+15.9 | 42.2+14.5 | 43.0+13.2 | 0.998 | ||
| Stone area | 114+53.4 | 164.1+71.4 | 126.8+47.2 | 111.9+42.1 | 137+60.1 | 0.022 | ||
| Density | 894.7+287.7 | 958.1+247 | 860.9+263.2 | 862.4+266.5 | 735.6+277.8 | 0.357 | ||
| Creatinine (preoperative) | 0.96+0.31 | 1.0+0 | 0.97+0.17 | 1.0+0.17 | 1.0+0 | 0.706 | ||
| Hct (preoperative) | 39.6+4.6 | 39.2+4.6 | 39.2+4.2 | 40.4+4 | 40.7+4.8 | 0.549 | ||
Postoperative demographic data
*CIRF: clinically insignificant residual fragment; *Hct: hematocrit
| Stone localization | ||||||||||
| Lower | Multiple | Middle | Pelvis | Upper | P-value | |||||
| First day success | Yes | n(%) | 114(61.3) | 24(57.1) | 162(79.4) | 540(88.2) | 66(78.6) | 0.009 | ||
| No | n(%) | 72(38.7) | 18(42.9) | 42(20.6) | 72(11.8) | 18(21.4) | ||||
| First month success | Yes | n(%) | 162(87.1) | 36(85.7) | 198(97.1) | 570(93.1) | 72(85.7) | 0.476 | ||
| No | n(%) | 24(12.9) | 6(14.3) | 6(2.9) | 42(6.9) | 12(14.3) | ||||
| Stent | Yes | n(%) | 144(77.4) | 42(100) | 174(85.3) | 432(70.6) | 66(78.6) | 0.235 | ||
| No | n(%) | 42(22.6) | 0(0.0) | 30(14.7) | 180(29.4) | 18(21.4) | ||||
| CIRF* | Yes | n(%) | 102(54.8) | 72(57.1) | 42(20.6) | 96(15.7) | 18(21.4) | <0.001 | ||
| No | n(%) | 42(45.2) | 9(42.9) | 81(79.4) | 258(84.3) | 33(78.6) | ||||
| Fever | Yes | n(%) | 6(3.2) | 0(0.0) | 18(8.8) | 18(2.9) | 0(0.0) | 0.482 | ||
| No | n(%) | 180(96.8) | 42(100) | 186(91.2) | 594(97.1) | 84(100.0) | ||||
| Pain | Yes | n(%) | 24(12.9) | 12(28.6) | 30(14.7) | 120(19.6) | 12(14.3) | 0.801 | ||
| No | n(%) | 162(87.1) | 30(71.4) | 174(85.3) | 492(80.4) | 72(85.7) | ||||
| Mucosal injury | Yes | n(%) | 12(6.5) | 0(0.0) | 6(2.9) | 48(7.8) | 0(0.0) | 0.63 | ||
| No | n(%) | 174(93.5) | 42(100) | 198(97.1) | 564(92.2) | 84(100.0) | ||||
| Hematuria | Yes | n(%) | 12(6.5) | 0(0.0) | 18(8.8) | 66(10.8) | 12(14.3) | 0.801 | ||
| No | n(%) | 174(93.5) | 42(100) | 186(91.2) | 546(89.2) | 72(85.7) | ||||
| Operation time | 58.4+13.6 | 68.2+19 | 56+12.3 | 57.7+13.3 | 64.7+10.9 | 0.082 | ||||
| Creatinine (postoperative)* | 1.03+0.17 | 1.0+0 | 1.0+0 | 1.03+0.17 | 1.01+0.05 | 0.793 | ||||
| Creatinine (1-month)* | 0.96+0.17 | 1.0+0 | 0.97+0.17 | 1.0+0 | 0.99+0.02 | 0.455 | ||||
| Hct (postoperative)* | 37.97+5.08 | 38.14+5 | 37.5+4.4 | 38.7+4.1 | 39.5+4.8 | 0.523 | ||||